Chronic Hepatitis B: Tenofovir and Entecavir compared

被引:0
|
作者
Kessing, Richard
机构
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2020年 / 58卷 / 09期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Tenofovir und Entecavir bei chronischer Hepatitis B
    Claus Niederau
    Gastro-News, 2019, 6 (4) : 14 - 15
  • [32] Cost-effectiveness of tenofovir alafenamide and entecavir in chronic hepatitis B in Saudi Arabia
    Al-Jedai, Ahmed
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2024, 30 (01): : 1 - 3
  • [33] Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients
    Kara, A., V
    Yildirim, Y.
    Ozcicek, F.
    Aldemir, M. N.
    Arslan, Y.
    Bayan, K.
    Celen, M. K.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2019, 82 (02) : 273 - 277
  • [34] Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience
    Tarsetti, Fabio
    Tarantino, Giuseppe
    Mosca, Piergiorgio
    Scarpellini, Emidio
    Fava, Giammarco
    CLINICAL MANAGEMENT ISSUES, 2015, 9 (04) : 95 - 100
  • [35] INFLUENCE OF HEPATIC STEATOSIS ON THE TREATMENT OUTCOMES OF ENTECAVIR AND TENOFOVIR IN PATIENTS WITH CHRONIC HEPATITIS B
    Jeon, Mi Young
    Kim, Seung Up
    Kim, David S.
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    GUT, 2018, 67 : A90 - A90
  • [36] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
  • [37] Efficacy of tenofovir dipivoxil plus entecavir in patients with HBeAg positive chronic hepatitis B
    Deng, Xiang
    Liu, Hua
    Jiang, Zaihui
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (07) : 1111 - 1117
  • [38] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Liu, Zhihong
    Sun, Jian
    Hou, Jinlin
    JAMA ONCOLOGY, 2019, 5 (06) : 915 - 915
  • [39] Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
    Hsu, Yao-Chun
    Wong, Grace Lai-Hung
    Chen, Chong
    Peng, Cheng-Yuan
    Yeh, Ming-Lun
    Cheung, Ka-Shing
    Toyoda, Hidenori
    Huang, Chung-Feng
    Huy Trinh
    Xie, Qing
    Enomoto, Masaru
    Liu, Li
    Yasuda, Satoshi
    Tanaka, Yasuhito
    Kozuka, Ritsuzo
    Tsai, Pei-Chien
    Huang, Yen-Tsung
    Wong, Christopher
    Huang, Rui
    Jang, Tyng-Yuan
    Hoang, Joseph
    Yang, Hwai-, I
    Li, Jiayi
    Lee, Dong-Hyun
    Takahashi, Hirokazu
    Zhang, Jian Q.
    Ogawa, Eiichi
    Zhao, Changqing
    Liu, Chenghai
    Furusyo, Norihiro
    Eguchi, Yuichiro
    Wong, Clifford
    Wu, Chao
    Kumada, Takashi
    Yuen, Man-Fung
    Yu, Ming-Lung
    Nguyen, Mindie H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (02): : 271 - 280
  • [40] Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients
    Durante-Mangoni, E.
    Vitrone, M.
    Parrella, A.
    Andini, R.
    Iossa, D.
    Ragone, E.
    Falco, E.
    Maiello, C.
    Utili, R.
    Zampino, R.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (03) : 319 - 325